Table 5.
Results of the semiquantitative scale assessment of microglial markers IBA1 (I), HLA-DR (H), and CD68 (C).
| Case | hCA3 Counts |
CA2/3 Counts |
CA1 Counts |
SUB Counts |
Total Counts per Sample |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | H | C | I | H | C | I | H | C | I | H | C | I | H | C | |
| HC1 | 3 | 3 | 3 | 2 | 3 | 2 | 0 | 2 | 2 | 1 | 2 | 2 | 6 | 10 | 9 |
| HC2 | 3 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 1 | 3 | 2 | 1 | 11 | 9 | 7 |
| HC3 | 2 | 0 | 1 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 0 | 1 | 7 | 0 | 5 |
| HC4 | 2 | 0 | 1 | 2 | 0 | 1 | 2 | 0 | 2 | 3 | 0 | 2 | 9 | 0 | 6 |
| HC5 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 0 | 2 | 1 | 3 | 8 | 6 |
| HC6 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 7 | 9 | 8 |
| HC7 | 0 | 1 | 2 | 1 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | 3 | 2 | 3 | 8 |
| HC8 | 3 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 1 | 2 | 1 | 2 | 9 | 1 | 7 |
| HC9 | 2 | 0 | 3 | 1 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 7 | 0 | 9 |
| AD1 | 0 | 0 | 3 | 0 | 2 | 2 | 0 | 1 | 4 | 0 | 1 | 3 | 0 | 4 | 12 |
| AD2 | 2 | 1 | 4 | 3 | 1 | 3 | 3 | 2 | 4 | 3 | 1 | 4 | 11 | 5 | 15 |
| AD3 | 0 | 1 | 3 | 2 | 0 | 3 | 1 | 2 | 4 | 0 | 2 | 3 | 3 | 5 | 13 |
| AD4 | 2 | 1 | 3 | 3 | 0 | n.a. | 2 | 3 | 4 | 3 | 4 | 4 | 10 | 8 | 11 |
| AD5 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 11 | 12 | 13 |
| AD6 | 2 | 2 | 4 | 3 | 0 | 3 | 3 | 3 | 4 | 2 | 2 | 3 | 10 | 7 | 14 |
| AD7 | 0 | 2 | 1 | 3 | 0 | 3 | 2 | 4 | 3 | 4 | 4 | 4 | 9 | 10 | 11 |
| AD8 | 0 | 4 | 4 | 1 | 3 | 3 | 1 | 4 | 4 | 0 | 4 | 4 | 2 | 15 | 15 |
| AD9 | 0 | 2 | 4 | 3 | 0 | 3 | 3 | 2 | 4 | 2 | 0 | 3 | 8 | 4 | 14 |
| AD10 | 3 | 0 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | 12 | 7 | 12 |
| AD11 | 3 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 3 | 3 | 11 | 11 | 9 |
Bold numbers represent totals from the individual subdivisions.